Suppr超能文献

从合并症角度看腹膜透析患者的选择

Peritoneal dialysis patient selection from a comorbidity perspective.

作者信息

Eroglu Eray, Heimbürger Olof, Lindholm Bengt

机构信息

Division of Nephrology, Department of Internal Medicine, Erciyes University School of Medicine, Kayseri, Turkey.

Division of Renal Medicine and Baxter Novum, Department of Clinical Science Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

出版信息

Semin Dial. 2022 Jan;35(1):25-39. doi: 10.1111/sdi.12927. Epub 2020 Oct 22.

Abstract

Despite many medical and socioeconomic advantages, peritoneal dialysis (PD) is an underutilized dialysis modality that in most countries is used by only 5%-20% of dialysis patients, while the vast majority are treated with in-center hemodialysis. Several factors may explain this paradox, such as lack of experience and infrastructure for training and monitoring of PD patients, organizational issues, overcapacity of hemodialysis facilities, and lack of economic incentives for dialysis centers to use PD instead of HD. In addition, medical conditions that are perceived (rightly or wrongly) as contraindications to PD represent barriers for the use of PD because of their purported potential negative impact on clinical outcomes in patients starting PD. While there are few absolute contraindications to PD, high age, comorbidities such as diabetes mellitus, obesity, polycystic kidney disease, heart failure, and previous history of abdominal surgery and renal allograft failure, may be seen (rightly or wrongly) as relative contraindications and thus barriers to initiation of PD. In this brief review, we discuss how the presence of these conditions may influence the strategy of selecting patients for PD, focusing on measures that can be taken to overcome potential problems.

摘要

尽管腹膜透析(PD)具有诸多医学和社会经济优势,但它却是一种未得到充分利用的透析方式,在大多数国家,只有5%-20%的透析患者采用这种方式,而绝大多数患者接受的是中心血液透析。有几个因素可以解释这一矛盾现象,比如缺乏培训和监测腹膜透析患者的经验及基础设施、组织问题、血液透析设施产能过剩,以及透析中心缺乏使用腹膜透析而非血液透析的经济激励措施。此外,被(无论正确与否)视为腹膜透析禁忌证的医学状况也是使用腹膜透析的障碍,因为它们据称可能对开始腹膜透析的患者的临床结局产生负面影响。虽然腹膜透析几乎没有绝对禁忌证,但高龄、糖尿病、肥胖症、多囊肾病、心力衰竭等合并症,以及既往腹部手术史和肾移植失败史,可能(无论正确与否)被视为相对禁忌证,从而成为开始腹膜透析的障碍。在这篇简短的综述中,我们讨论这些情况的存在如何影响选择腹膜透析患者的策略,重点关注可以采取哪些措施来克服潜在问题。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验